Panthera Resources PLC confirms its ordinary shares will remain listed and traded on the London Stock Exchange. Additionally, the company plans to file an application with the OTC Markets Group, expanding trading opportunities and investor access across broader markets, signaling a strategic step toward increased liquidity and market presence.
Show more
Panthera Resources PLC has announced that its ordinary shares will continue to be traded on the London Stock Exchange (LSE), reaffirming its commitment to maintaining a strong presence in this key international market. The company further revealed plans to file an application with the OTC Markets Group, aiming to broaden its visibility and trading accessibility for global investors.
Key highlights include:
-
Continued LSE listing preserves Panthera’s connection to a major equity market, supporting shareholder confidence and institutional interest
-
Filing with OTC Markets Group is designed to enable trading in additional markets, enhancing liquidity options and investor reach
-
OTC listing would complement existing exchange presence, expanding Panthera’s footprint in the US and other jurisdictions
-
This dual-market strategy aligns with Panthera’s growth ambitions and efforts to attract diverse investment sources
-
The company remains focused on operational progress and delivering shareholder value amid favorable market conditions
-
This development marks an important milestone in Panthera Resources’ strategic roadmap, reflecting its adaptive approach in a dynamic global marketplace.
Sources: Panthera Resources official statements, London Stock Exchange, OTC Markets Group releases.
Stay Ahead – Explore Now!
Asston Pharmaceuticals Secures $301,090 Purchase Order, Signaling Strong Demand for Specialty Drug Portfolio
Advertisement
Advertisement